img

Global Bulimia Nervosa Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Bulimia Nervosa Treatment Market Research Report 2024

Bulimia nervosa also known as bulimia is an eating disorder associated with binge eating that follow the compensatory procedures. 
According to MRAResearch’s new survey, global Bulimia Nervosa Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bulimia Nervosa Treatment market research.
Key companies engaged in the Bulimia Nervosa Treatment industry include Eli Lilly, AstraZeneca, Allergan, Pfizer, Bristol-Myers Squibb, Johnson&Johnson and GlaxoSmithKline, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Bulimia Nervosa Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Bulimia Nervosa Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Bulimia Nervosa Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
AstraZeneca
Allergan
Pfizer
Bristol-Myers Squibb
Johnson&Johnson
GlaxoSmithKline
Segment by Type
Drug Treatment
Psychological Treatment
Nutrition Therapy
Others

Segment by Application


Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Bulimia Nervosa Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bulimia Nervosa Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drug Treatment
1.2.3 Psychological Treatment
1.2.4 Nutrition Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bulimia Nervosa Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bulimia Nervosa Treatment Market Perspective (2018-2033)
2.2 Bulimia Nervosa Treatment Growth Trends by Region
2.2.1 Global Bulimia Nervosa Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Bulimia Nervosa Treatment Historic Market Size by Region (2018-2023)
2.2.3 Bulimia Nervosa Treatment Forecasted Market Size by Region (2024-2033)
2.3 Bulimia Nervosa Treatment Market Dynamics
2.3.1 Bulimia Nervosa Treatment Industry Trends
2.3.2 Bulimia Nervosa Treatment Market Drivers
2.3.3 Bulimia Nervosa Treatment Market Challenges
2.3.4 Bulimia Nervosa Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bulimia Nervosa Treatment Players by Revenue
3.1.1 Global Top Bulimia Nervosa Treatment Players by Revenue (2018-2023)
3.1.2 Global Bulimia Nervosa Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Bulimia Nervosa Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bulimia Nervosa Treatment Revenue
3.4 Global Bulimia Nervosa Treatment Market Concentration Ratio
3.4.1 Global Bulimia Nervosa Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bulimia Nervosa Treatment Revenue in 2022
3.5 Bulimia Nervosa Treatment Key Players Head office and Area Served
3.6 Key Players Bulimia Nervosa Treatment Product Solution and Service
3.7 Date of Enter into Bulimia Nervosa Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bulimia Nervosa Treatment Breakdown Data by Type
4.1 Global Bulimia Nervosa Treatment Historic Market Size by Type (2018-2023)
4.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Type (2024-2033)
5 Bulimia Nervosa Treatment Breakdown Data by Application
5.1 Global Bulimia Nervosa Treatment Historic Market Size by Application (2018-2023)
5.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Bulimia Nervosa Treatment Market Size (2018-2033)
6.2 North America Bulimia Nervosa Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Bulimia Nervosa Treatment Market Size by Country (2018-2023)
6.4 North America Bulimia Nervosa Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bulimia Nervosa Treatment Market Size (2018-2033)
7.2 Europe Bulimia Nervosa Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Bulimia Nervosa Treatment Market Size by Country (2018-2023)
7.4 Europe Bulimia Nervosa Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bulimia Nervosa Treatment Market Size (2018-2033)
8.2 Asia-Pacific Bulimia Nervosa Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bulimia Nervosa Treatment Market Size (2018-2033)
9.2 Latin America Bulimia Nervosa Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Bulimia Nervosa Treatment Market Size by Country (2018-2023)
9.4 Latin America Bulimia Nervosa Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bulimia Nervosa Treatment Market Size (2018-2033)
10.2 Middle East & Africa Bulimia Nervosa Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Bulimia Nervosa Treatment Introduction
11.1.4 Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Bulimia Nervosa Treatment Introduction
11.2.4 AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Bulimia Nervosa Treatment Introduction
11.3.4 Allergan Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.3.5 Allergan Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bulimia Nervosa Treatment Introduction
11.4.4 Pfizer Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Bulimia Nervosa Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson&Johnson
11.6.1 Johnson&Johnson Company Detail
11.6.2 Johnson&Johnson Business Overview
11.6.3 Johnson&Johnson Bulimia Nervosa Treatment Introduction
11.6.4 Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.6.5 Johnson&Johnson Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Bulimia Nervosa Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bulimia Nervosa Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Psychological Treatment
Table 4. Key Players of Nutrition Therapy
Table 5. Key Players of Others
Table 6. Global Bulimia Nervosa Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Bulimia Nervosa Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Bulimia Nervosa Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Bulimia Nervosa Treatment Market Share by Region (2018-2023)
Table 10. Global Bulimia Nervosa Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Bulimia Nervosa Treatment Market Share by Region (2024-2033)
Table 12. Bulimia Nervosa Treatment Market Trends
Table 13. Bulimia Nervosa Treatment Market Drivers
Table 14. Bulimia Nervosa Treatment Market Challenges
Table 15. Bulimia Nervosa Treatment Market Restraints
Table 16. Global Bulimia Nervosa Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Bulimia Nervosa Treatment Market Share by Players (2018-2023)
Table 18. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulimia Nervosa Treatment as of 2022)
Table 19. Ranking of Global Top Bulimia Nervosa Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Bulimia Nervosa Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bulimia Nervosa Treatment Product Solution and Service
Table 23. Date of Enter into Bulimia Nervosa Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bulimia Nervosa Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Bulimia Nervosa Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Bulimia Nervosa Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Bulimia Nervosa Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Bulimia Nervosa Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Bulimia Nervosa Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Bulimia Nervosa Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Bulimia Nervosa Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Bulimia Nervosa Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Bulimia Nervosa Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Bulimia Nervosa Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Bulimia Nervosa Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Bulimia Nervosa Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Bulimia Nervosa Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Bulimia Nervosa Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Bulimia Nervosa Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Bulimia Nervosa Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Bulimia Nervosa Treatment Product
Table 51. Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Bulimia Nervosa Treatment Product
Table 56. AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Allergan Company Detail
Table 59. Allergan Business Overview
Table 60. Allergan Bulimia Nervosa Treatment Product
Table 61. Allergan Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 62. Allergan Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Bulimia Nervosa Treatment Product
Table 66. Pfizer Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bristol-Myers Squibb Company Detail
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Bulimia Nervosa Treatment Product
Table 71. Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Johnson&Johnson Company Detail
Table 74. Johnson&Johnson Business Overview
Table 75. Johnson&Johnson Bulimia Nervosa Treatment Product
Table 76. Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 77. Johnson&Johnson Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Bulimia Nervosa Treatment Product
Table 81. GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2018-2023) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bulimia Nervosa Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Bulimia Nervosa Treatment Market Share by Type: 2022 VS 2033
Figure 3. Drug Treatment Features
Figure 4. Psychological Treatment Features
Figure 5. Nutrition Therapy Features
Figure 6. Others Features
Figure 7. Global Bulimia Nervosa Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Bulimia Nervosa Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Bulimia Nervosa Treatment Report Years Considered
Figure 13. Global Bulimia Nervosa Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Bulimia Nervosa Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Bulimia Nervosa Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Bulimia Nervosa Treatment Market Share by Players in 2022
Figure 17. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulimia Nervosa Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Bulimia Nervosa Treatment Revenue in 2022
Figure 19. North America Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Bulimia Nervosa Treatment Market Share by Country (2018-2033)
Figure 21. United States Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Bulimia Nervosa Treatment Market Share by Country (2018-2033)
Figure 25. Germany Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Bulimia Nervosa Treatment Market Share by Region (2018-2033)
Figure 33. China Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Bulimia Nervosa Treatment Market Share by Country (2018-2033)
Figure 41. Mexico Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Bulimia Nervosa Treatment Market Share by Country (2018-2033)
Figure 45. Turkey Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Bulimia Nervosa Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 52. Johnson&Johnson Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Bulimia Nervosa Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed